ACLX vs. OLMA

In the year-to-date period, ACLX achieves a -16.96% return, which is significantly lower than OLMA's -9.09% return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Arcellx Inc (ACLX) and Olema Pharmaceuticals, Inc. (OLMA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current ACLX Sharpe Ratio is 0.47, which is higher than the OLMA Sharpe Ratio of -0.58. The chart below compares the historical Sharpe Ratios of ACLX and OLMA, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Neither ACLX nor OLMA has paid dividends to shareholders.

The maximum ACLX drawdown since its inception was -62.33%, smaller than the maximum OLMA drawdown of -96.26%. Use the drawdown chart below to compare losses from any high point for ACLX and OLMA.

Arcellx Inc (ACLX) and Olema Pharmaceuticals, Inc. (OLMA) have volatilities of 24.69% and 24.53%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between Arcellx Inc and Olema Pharmaceuticals, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.